Skip to content

Research on the Application of Wearable Sensors for Real-Time Detection of Tuberculosis

Research on the Application of Wearable Sensors for Real-Time Detection of Tuberculosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116957
Enrollment
Unknown
Registered
2026-01-16
Start date
2026-01-18
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Interventions

Gold Standard:ELISA Testing (Ag85B,etc.)
Index test:Multifunctional Portable/Wearable Biosensing Electronic System testing Ag85, etc.

Sponsors

West China Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Tuberculosis Group Inclusion Criteria: A confirmed case meets any of the following conditions: sputum smear-positive pulmonary tuberculosis; culture-positive pulmonary tuberculosis; pulmonary imaging consistent with active pulmonary tuberculosis; positive molecular biological testing; pathological diagnosis of tuberculosis lesions in lung or pleural specimens. Latent Tuberculosis Inclusion Criteria: Individuals aged 18–80 years who are family members of active TB patients or have a history of exposure to active TB, with positive TB-IGRA, PPD, or T-SPOT® test results, and no clinical, bacteriological, or radiological evidence of active TB, or who are clinically diagnosed with latent tuberculosis following assessment by a clinician. 2. Healthy control group inclusion criteria: Negative r-interferon release assay, no prior history of tuberculosis, absence of tuberculosis-related clinical symptoms, and normal chest X-ray findings. No significant discomfort, no long-term medication use, and no underlying medical conditio

Exclusion criteria

Exclusion criteria: Exclusion Criteria: Patients with mixed infections; patients with solid tumors or hematologic malignancies; critically ill patients with organ failure; severe autoimmune diseases, use of immunosuppressants or immunoenhancers; pregnancy or lactation; patients who refuse to sign informed consent.Inclusion Criteria for the Tuberculosis Group: Individuals meeting any of the following criteria are considered confirmed cases: smear-positive pulmonary tuberculosis; culture-positive pulmonary tuberculosis; chest imaging findings consistent with active pulmonary tuberculosis; positive molecular biology test results; pathological diagnosis of tuberculosis from lung or pleural lesion specimens; and no prior history of antituberculosis treatment. Inclusion Criteria for the Healthy Control Group: Negative interferon-gamma release assay, no history of tuberculosis, absence of tuberculosis-related clinical symptoms, and normal chest X-ray findings. No significant discomfort, no long-term medication use, and no underlying medical conditions.

Design outcomes

Primary

MeasureTime frame
Ag85B in Exhaled breath condensate;

Secondary

MeasureTime frame
Specificity;Sensitivity;Accuracy;

Countries

China

Contacts

Public ContactBinwu Ying

West China Hospital

yingbinwu@scu.edu.cn+86 28 8542 2533

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026